Fingerprint
Dive into the research topics of 'Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state
Miki Tongu, Nanae Harashima, Koji Tamada, Lieping Chen, Mamoru Harada
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations